Mylan intros generic TecfideraBiogen’s Tecfidera is indicated for the treatment of relapsing forms of multiple sclerosis and is the first generic of any MS treatment in an oral solid dosage form. Sun Pharma releases generic ProtonixThe Protonix brand had a market value of approximately $43 million for the last 12 months ending in June 2020, according to IQVIA. Novartis wins patent protection for Gilenya A Delaware district court has decided that HEC Pharm's generic fingolimod will infringe the dosage regimen patent for Novartis' Gilenya. Eugia Pharma obtains FDA blessing for generic Nolvadex Eugia Pharma's generic Nolvadex provides a treatment for certain types of breast cancer in women and men. Lannett to distribute Respirent’s generic Flovent Diskus Flovent Diskus had a market value of $94 million for the 12 months ended June 2020, according to IQVIA. Aurobindo gets FDA OK for generic Robaxin Aurobindo's methocarbamol tablets are available in a dosage strength of 750 mg. Camber launches generic Effexor Camber’s generic Effexor is available in dosage strengths of 37.5 mg 75 mg, and 150 mg. Vitruvias intros generic K-Tab K-Tab and potassium chloride extended-release tablets had a market value of approximately $346 million for the 12 months ended March 2020, according to IQVIA. Lupin launches generic Zyflo CR Zileuton extended-release tablets had an annual market value of approximately $40 million, according to IQVIA June 2020 data. Aurobindo gets FDA green light for generic ProAmatine Aurobindo's generic ProAmatine tablets provide a treatment for orthostatic hypotension. First Previous 150 151 152 153 154 Next Last
